Hair for brain trade-off, a metabolic bypass for encephalization

Por Dror, Yosef, Hopp, Michael
Publicado em 2014

Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study

Por Cutolo, Maurizio, Hopp, Michael, Liebscher, Stefan, Dasgupta, Bhaskar, Buttgereit, Frank
Publicado no RMD Open (2017)

A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients w...

Por Ahmedzai, Sam H, Nauck, Friedemann, Bar-Sela, Gil, Bosse, Björn, Leyendecker, Petra, Hopp, Michael
Publicado em 2012

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain

Por Ahmedzai, Sam H., Leppert, Wojciech, Janecki, Marcin, Pakosz, Artur, Lomax, Mark, Duerr, Heike, Hopp, Michael
Publicado no Support Care Cancer (2014)

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, P...

Por Oertel, Wolfgang H., Hallström, Yngve, Saletu-Zyhlarz, Gerda M., Hopp, Michael, Bosse, Björn, Trenkwalder, Claudia
Publicado no CNS Drugs (2016)

Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled...

Por Löwenstein, Oliver, Leyendecker, Petra, Lux, Eberhard A, Blagden, Mark, Simpson, Karen H, Hopp, Michael, Bosse, Björn, Reimer, Karen
Publicado em 2010